The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Implantable Collamer Lens Market From 2026 To 2030?
The implantable collamer lens market size has experienced substantial expansion in recent years. This market is projected to expand from $20.77 billion in 2025 to $22.2 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. Historical expansion in this sector can be linked to a rise in the occurrence of refractive vision disorders, a heightened need for surgical solutions to vision correction, continuous improvements in ophthalmic implant technology, increased adoption of ICL procedures, and the proliferation of dedicated ophthalmic clinics.
The implantable collamer lens market size is anticipated to demonstrate significant expansion in the coming years. It is predicted to reach $28.74 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.7%. This projected growth throughout the forecast period stems from factors such as the increasing embrace of premium vision correction options, a heightened emphasis on minimally invasive ophthalmic surgical procedures, the broadening scope of elective eye care, rising investments in cutting-edge ophthalmology technologies, and improved patient understanding of the benefits of ICLs. Noteworthy trends during this period include the growing uptake of EVO implantable collamer lenses, an increase in the use of laser-assisted implantation techniques, a rising demand for reversible vision correction solutions, the expansion of customized lens designs, and an enhanced focus on ensuring long-term visual stability.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp
Which Important Drivers Are Guiding The Implantable Collamer Lens Market Growth?
The implantable collamer lens market is expected to be propelled by the increasing incidence of vision disorders. Vision disorders describe conditions that hinder clear sight, characterized by a gradual decline in visual acuity and eye well-being. These disorders are escalating globally due to factors such as an aging population, increased screen time, and the rising prevalence of conditions like myopia and age-related macular degeneration. Implantable Collamer Lenses (ICLs) present an effective solution for correcting vision disorders such as myopia, hyperopia, and astigmatism, offering a safe and reversible alternative to traditional refractive surgeries like LASIK. For instance, in August 2023, a report published by the World Health Organization, a Switzerland-based specialized agency of the United Nations, stated that over 2.2 billion people globally suffer from near or distance vision impairment, with 1 billion of these cases being preventable or still unaddressed. Therefore, the growing prevalence of vision disorders is stimulating the expansion of the implantable collamer lens market.
What Segment Categories Shape The Implantable Collamer Lens Market Segment Landscape?
The implantable collamer lens market covered in this report is segmented –
1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)
2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques
3) By Application: Myopia, Hyperopia, Astigmatism
4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User
Subsegments:
1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia
2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia
What Trends Are Influencing The Evolution Of The Implantable Collamer Lens Market?
Leading firms within the implantable collamer lens market are concentrating on advancements in technology, particularly developing biocompatible, minimally invasive lens implants capable of correcting various refractive errors without corneal tissue removal, aiming to enhance patient results and lessen reliance on eyewear. These Biocompatible Minimally Invasive Implantable Lenses facilitate secure and reversible vision correction through integration with the eye’s inherent structure, providing quick interventions and ensuring significant patient contentment. As an illustration, in March 2024, STAAR Surgical Company, which is a U.S.-based firm specializing in ophthalmic medical devices, reported that more than three million EVO ICL lenses had been surgically placed worldwide. The EVO ICL addresses myopia, encompassing cases with or without astigmatism, as well as presbyopia, through a 20–30 minute procedure where the lens is positioned between the iris and the eye’s natural crystalline lens. This biocompatible and removable lens presents a cutting-edge substitute for traditional glasses and contact lenses, assisting numerous patients in attaining enhanced vision both safely and efficiently.
Who Are The Companies Operating Across The Implantable Collamer Lens Market Value Chain?
Major companies operating in the implantable collamer lens market are STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen)*, Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, Visiogen Inc.
Get The Full Implantable Collamer Lens Market Report:
https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report
Which Geographic Region Dominates The Implantable Collamer Lens Market?
North America was the largest region in the implantable collamer lens market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Implantable Collamer Lens Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp
Browse Through More Reports Similar to the Global Implantable Collamer Lens Market 2026, By The Business Research Company
Corneal Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/corneal-implants-global-market-report
Prescription Lens Market Report 2026
https://www.thebusinessresearchcompany.com/report/prescription-lens-global-market-report
Cataract Surgery Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model